Jillian B. Thomsen

VP & Chief Accounting Officer, Nektar Therapeutics.

Companies

Nektar TherapeuticsChief financial officer Nov 18, 2022 to Feb 17, 2023¹
Nektar TherapeuticsVP & Chief Accounting Officer May 1, 2008 to Aug 17, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Nektar Therapeutics NKTR313,497 shares³$11.4M at $36.45Feb 16, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 16, 2023Sold 10,267 shares at $3.00 of Nektar Therapeutics³
Nov 16, 2022Sold 11,095 shares at $3.57 of Nektar Therapeutics⁴
Aug 16, 2022Sold 2,006 shares at $4.76 of Nektar Therapeutics⁵
Aug 15, 2022Granted 165,938 shares of Nektar Therapeutics⁵
May 16, 2022Sold 5,841 shares at $3.95 of Nektar Therapeutics⁶
May 15, 2022Granted 10,950 shares of Nektar Therapeutics⁶
Feb 16, 2022Sold 2,363 shares at $10.95 of Nektar Therapeutics⁷
Dec 16, 2021Granted 21,200 shares of Nektar Therapeutics⁸
Nov 16, 2021Sold 6,741 shares at $13.16 of Nektar Therapeutics⁹
Nov 15, 2021Granted 14,900 shares of Nektar Therapeutics⁹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARNektar Therapeutics, Chief financial officer
2
SEC EDGARNektar Therapeutics, VP & Chief Accounting Officer
3
SEC EDGARNektar Therapeutics shares after the filing of Feb 16, 2023
4
SEC EDGARForm 4 filed Nov 18, 2022
5
SEC EDGARForm 4 filed Aug 17, 2022
6
SEC EDGARForm 4 filed May 17, 2022
7
SEC EDGARForm 4 filed Feb 18, 2022
8
SEC EDGARForm 4 filed Dec 20, 2021
9
SEC EDGARForm 4 filed Nov 17, 2021